BIOMAT Database Logo BIOMAT Database Logo

Effect of erythropoietin on anaemia in patients with myeloma receiving haemodialysis. 1990

J Taylor, and R A Mactier, and W K Stewart, and I S Henderson
Renal Unit, Ninewells Hospital and Medical School, Dundee.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D004921 Erythropoietin Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006454 Hemoglobins The oxygen-carrying proteins of ERYTHROCYTES. They are found in all vertebrates and some invertebrates. The number of globin subunits in the hemoglobin quaternary structure differs between species. Structures range from monomeric to a variety of multimeric arrangements. Eryhem,Ferrous Hemoglobin,Hemoglobin,Hemoglobin, Ferrous
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000740 Anemia A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN. Anemias

Related Publications

J Taylor, and R A Mactier, and W K Stewart, and I S Henderson
Erythropoietin, aluminium, and anaemia in patients on haemodialysis.
April 1990, Lancet (London, England),
J Taylor, and R A Mactier, and W K Stewart, and I S Henderson
Erythropoietin, aluminium, and anaemia in patients on haemodialysis.
February 1990, Lancet (London, England),
J Taylor, and R A Mactier, and W K Stewart, and I S Henderson
Erythropoietin, aluminium, and anaemia in patients on haemodialysis.
July 1990, Lancet (London, England),
J Taylor, and R A Mactier, and W K Stewart, and I S Henderson
Treatment of anaemia in haemodialysis patients with recombinant erythropoietin.
January 1989, Nephron,
J Taylor, and R A Mactier, and W K Stewart, and I S Henderson
Effect of treatment of anaemia with erythropoietin on neuromuscular function in patients on long term haemodialysis.
January 1992, Scandinavian journal of urology and nephrology,
J Taylor, and R A Mactier, and W K Stewart, and I S Henderson
Correction of anaemia in haemodialysis patients with recombinant human erythropoietin.
January 1993, International urology and nephrology,
J Taylor, and R A Mactier, and W K Stewart, and I S Henderson
Is erythropoietin safe in haemodialysis patients with multiple myeloma ?
January 1994, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,
J Taylor, and R A Mactier, and W K Stewart, and I S Henderson
Treatment of anaemia in haemodialysis patients with erythropoietin: long-term effects on exercise capacity.
April 1993, Clinical science (London, England : 1979),
J Taylor, and R A Mactier, and W K Stewart, and I S Henderson
Use of recombinant erythropoietin in the treatment of anaemia associated with multiple myeloma in a haemodialysis patient.
January 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
J Taylor, and R A Mactier, and W K Stewart, and I S Henderson
Effect of desferrioxamine on anaemia of haemodialysis patients.
January 1988, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Copied contents to your clipboard!